Medicine
Aurlumyn 100 mcg/1 mL injection
Aurlumyn 100 mcg/1 mL injection is a prescription medicine containing Iloprost for intravenous use, marketed by BTG International, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Unopened vials of AURLUMYN are stable until the date indicated…
Key facts
- Active ingredient (INN)
- Iloprost
- Brand
- Aurlumyn
- Strength
- 100 mcg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 vial of 1 mL
- Marketing authorisation holder
- BTG International
- Manufacturer
- BTG International
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Unopened vials of AURLUMYN are stable until the date indicated on the package when stored at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AC11 Iloprost
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 August 2025
- Identifiers
- RxCUI 2680303, 2680309DailyMed set ID 34036fc0-6832-d066-e063-6394a90a18a4NDC 50633-340Application NDA217933
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 1 mL in 1 vial, single-dose | 50633-340-01 | BTG International | 1 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Iloprost is a prostacycline indicated for the treatment of severe frostbite in adults to reduce the risk of digit amputations. It is available as injection for intravenous use. MedsAcross supplies Iloprost for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about IloprostFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AURLUMYN prescribing information (BTG International) · U.S. National Library of Medicine, DailyMed
- Ventavis: European public assessment report (EPAR) · European Medicines Agency
Need Aurlumyn 100 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.